<DOC>
	<DOC>NCT02707744</DOC>
	<brief_summary>It is an observational study in patients with heart failure investigating the incidence of arrhythmias using a wearable device which can monitor heart rhythm for up to 14 days. In addition to gathering routine clinical information, research assessments include a symptoms questionnaire and a corridor walk test. Patients will be followed for clinical events (interventions for arrhythmias, hospitalisation, death) for up to 5 years.</brief_summary>
	<brief_title>A Study of Prolonged Electrocardiographic Monitoring in Patients With Heart Failure in Sinus Rhythm or Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1. Heart Failure 2. Treated with Loop Diuretics for at least six weeks 3. Willing and legally able to sign informed consent 4. At least 18 years of age 5. New York Heart Association (NYHA) class II IV 1. Myocardial infarction in the previous six weeks, 2. Implanted pacemaker, including cardiac resynchronisation device, or defibrillator 3. Already participating in an interventional randomized controlled trial assessing effects on morbidity and mortality (this study does not preclude participation in future clinical trials).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Ambulatory ECG monitor</keyword>
</DOC>